Regulatory News ODAC votes to recommend neuroblastoma drug for first-ever approval based on trial using external control arm October 06, 2023Vol.49 No.37By Jacquelyn Cobb and Paul Goldberg
FreeIn the Archives Ashani Weeraratna and Bill Nelson talk about the early days of cancer research at Johns Hopkins October 06, 2023Vol.49 No.37
ASCO’s Julie Gralow: “There was clearly a shortage of drug, but there was a bigger problem of maldistribution” September 29, 2023Vol.49 No.36By Jacquelyn Cobb
Capitol Hill Most NIH activities will cease immediately if government shuts down September 29, 2023Vol.49 No.36By Matthew Bin Han Ong
Film & TVFree Women physicians are underrepresented in film, a study led by oncologists finds September 29, 2023Vol.49 No.36By Alexandria Carolan
Guest Editorial “Oppenheimer” is a reminder to physicians, scientists to act to prevent nuclear war September 29, 2023Vol.49 No.36By Robert Peter Gale and Andreas Hochhaus
Conversation with The Cancer Letter AACR creates an alliance of academic cancer centersFoti, Willman, Weiner, and Winn tell us what the new group will seek to accomplish September 22, 2023Vol.49 No.35By Paul Goldberg
Capitol Hill NCI braces for funding cuts, shutdown September 22, 2023Vol.49 No.35By Matthew Bin Han Ong
White House White House announces 25 Cancer Moonshot initiatives, including $240M in ARPA-H funds September 22, 2023Vol.49 No.35By Matthew Bin Han Ong
